A Phase I Study Combining Escalating Doses of Radiolabeled BC8 (Anti-CD45) Antibody with Fludarabine, Low Dose TBI, PBSC Infusion and Post-Transplant Immunosuppression with Cyclosporine and Mycophenolate Mofetil to Establish Mixed or Full Donor Chimerism